Creative Medical Technology Holdings Inc (CELZ) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive trading signals, weak financial performance, absence of recent news, and neutral trading sentiment suggest that this stock does not currently present a compelling investment opportunity.

Technical Analysis

The MACD is slightly positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 42.475, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.784), but there is no strong technical signal for a breakout or reversal.

Positive Catalysts

NULL identified. No recent news, no significant insider or hedge fund activity, and no congress trading data.

Neutral/Negative Catalysts

and declining EPS (-36% YoY). The company has no revenue growth and operates at a significant loss.

Financial Performance

In Q3 2025, revenue remained at $0 with no growth. Net income improved by 18.82% YoY but remains negative at -$1,235,934. EPS dropped by 36% YoY to -0.48, and gross margin, while improving, is still negative at -3019.27%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

Analyst Rating

Wall Street analysts forecast CELZ stock price to rise

Buy

Hold

Sell

Current: 1.810

Low

Averages

High

Current: 1.810

Low

Averages

High

Roth Capital

Jonathan Aschoff

Buy

downgrade

$26 -> $20

AI Analysis

2025-06-04

Reason